Rectal Adenocarcinoma Presenting as a Cervical Mass: A Case Report.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
medline:
29
11
2023
pubmed:
27
11
2023
entrez:
27
11
2023
Statut:
epublish
Résumé
BACKGROUND Invasive cervical tumors are often seen in clinical practice. However, there are multiple structures within the pelvis, and invasion of the cervix from another site must be included in the differential diagnosis. In such cases, a multidisciplinary approach is needed to define the organ of tumor origin. Ensuring proper staging and histologic analysis are critical for optimal management. CASE REPORT We present a case of a 68-year-old woman who presented to her gynecologist with painless post-menopausal vaginal bleeding. She was diagnosed with a locally aggressive cervical adenocarcinoma, which was histologically confirmed by an in-office biopsy. She was referred to the gynecologic oncology service at a tertiary care hospital for definitive management, where a thorough clinical workup was performed. Physical exam revealed that the mass had invaded the anterior rectal wall. Through a multidisciplinary approach and a repeat biopsy, she was correctly diagnosed with an invasive rectal adenocarcinoma. She was treated with neoadjuvant chemoradiotherapy and underwent curative surgery. Had she been incorrectly treated as having a primary cervical adenocarcinoma, there would have been no role for surgery. The change in the organ of primary drastically altered the patient's management and outcome. She is currently undergoing surveillance with cross-sectional imaging. CONCLUSIONS Cervical masses originating from non-gynecologic organs can be difficult to differentiate on physical exam and histologic analysis. When a mass involves the rectum, an invasive primary rectal adenocarcinoma must be included in the differential. This will have a significant impact on patient management and ultimately on patient survival.
Identifiants
pubmed: 38011075
pii: 941884
doi: 10.12659/AJCR.941884
pmc: PMC10697495
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e941884Références
Clin Gastroenterol Hepatol. 2010 Oct;8(10):A26
pubmed: 20478400
Am J Obstet Gynecol. 2017 Mar;216(3):276.e1-276.e6
pubmed: 27810552
Am J Surg Pathol. 2018 Aug;42(8):989-1000
pubmed: 29851704
Gynecol Oncol. 2004 Aug;94(2):363-7
pubmed: 15297173
Int J Gynecol Cancer. 2021 Apr;31(4):518-523
pubmed: 32920534
Oncotarget. 2016 Nov 29;7(48):79787-79796
pubmed: 27806332
Lancet Oncol. 2021 Apr;22(4):538-547
pubmed: 33794207
Oncology. 2019;97(3):125-134
pubmed: 31266037
Anticancer Res. 2013 Nov;33(11):4989-94
pubmed: 24222140
Gynecol Oncol. 2010 Jan;116(1):140-6
pubmed: 19880165
Ann Oncol. 2014 Mar;25(3):651-657
pubmed: 24504447
Am J Surg Pathol. 2020 Dec;44(12):1699-1711
pubmed: 32910021